Magda Michna
Chief Development OfficerDr. Magda Michna, Ph.D., is Chief Development Officer of STAAR Surgical Company from March 2025 and served as its Chief Clinical, Regulatory and Medical Affairs Officer since April 2023. She served as Chief Global Clinical & Regulatory Affairs Officer of AcuFocus, Inc. since April 2018. Dr. Michna served as Chief Clinical Officer of Presbia PLC from February 12, 2018 to March 30, 2018. Dr. Michna served as Vice President of Clinical Affairs at Presbia PLC from December 15, 2017 to 2018. Dr. Michna is an experienced global clinical development and medical affairs professional with more than 12 years of experience in ophthalmic clinical research and development. Her background includes academic research in ophthalmology and clinical development of different classes of ophthalmic medical devices. Her industry career began as a Vision Scientist at VISTAKON®, a division of Johnson & Johnson Vision from 2008 to 2012, which she joined following an academic Research Fellowship with the Vision Research Group at McGill University’s Department of Ophthalmology from 2005 to 2008. Dr. Michna is a US representative on the ISO committee for ophthalmic implants and brings with her a wealth of knowledge in the ophthalmic space. Dr. Michna holds a Doctor of Philosophy degree in optical physics and a bachelor's degree from the University of Melbourne, Australia.
公司职务
- 公司名称STAAR Surgical Company股票代码STAA职务Chief Development Officer共事同僚
- WFWarren FoustCEO, President & Director
- NCNeal Clifton BradsherIndependent Chairman of the Board
- DJDeborah J. AndrewsExecutive VP & CFO
- BPBen ParkChief Technology Officer
- CJConnie JohnsonDirector of Investor Relations
- LELouis E. SilvermanIndependent Director
- LYLilian Y. ZhouIndependent Director
- BWBrian WilliamsMember of Optometric Advisory Council
